22nd Century Announces Pricing of $5.25 Million Public Offering
BUFFALO, N.Y., Oct. 17, 2023 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII) (the Company), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, he…